Edwards Lifesciences Corporation NYSE:EW

Edwards Lifesciences stock price today

$80.24
+4.58
+6.07%
Financial Health
0
1
2
3
4
5
6
7
8
9

Edwards Lifesciences stock price monthly change

-16.86%
month

Edwards Lifesciences stock price quarterly change

-16.86%
quarter

Edwards Lifesciences stock price yearly change

-0.73%
year

Edwards Lifesciences key metrics

Market Cap
43.35B
Enterprise value
50.30B
P/E
33.55
EV/Sales
9.34
EV/EBITDA
26.15
Price/Sales
9.36
Price/Book
8.67
PEG ratio
16.17
EPS
2.33
Revenue
6.14B
EBITDA
1.88B
Income
1.41B
Revenue Q/Q
9.49%
Revenue Y/Y
11.68%
Profit margin
28.28%
Oper. margin
32.49%
Gross margin
79.93%
EBIT margin
32.49%
EBITDA margin
30.71%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Edwards Lifesciences stock price history

Edwards Lifesciences stock forecast

Edwards Lifesciences financial statements

Average Price Target
Last Year

$74.15

Potential downside: -7.58%

Based on estimate of 11 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Edwards Lifesciences Corporation (NYSE:EW): Profit margin
Jun 2023 1.53B 307.1M 20.07%
Sep 2023 1.48B 384.9M 25.99%
Dec 2023 1.53B 369.9M 24.11%
Mar 2024 1.59B 351.9M 22.02%
Edwards Lifesciences Corporation (NYSE:EW): Debt to assets
Jun 2023 9004000000 2.55B 28.4%
Sep 2023 9370800000 2.64B 28.21%
Dec 2023 9363200000 2.64B 28.24%
Mar 2024 9736300000 2.54B 26.19%
Edwards Lifesciences Corporation (NYSE:EW): Cash Flow
Jun 2023 33.6M 70.2M 52.1M
Sep 2023 411.5M 89M -143.3M
Dec 2023 136.6M 14.1M -413.2M
Mar 2024 -53.5M 63.1M 61.7M

Edwards Lifesciences alternative data

Edwards Lifesciences Corporation (NYSE:EW): Employee count
Sep 2023 17,300
Oct 2023 17,300
Nov 2023 17,300
Dec 2023 17,300
Jan 2024 17,300
Feb 2024 17,300
Mar 2024 19,800
Apr 2024 19,800
May 2024 19,800
Jun 2024 19,800
Jul 2024 19,800

Edwards Lifesciences other data

79.26% -2.16%
of EW is owned by hedge funds
500.29M -14.02M
shares is hold by hedge funds

Edwards Lifesciences Corporation (NYSE:EW): Insider trades (number of shares)
Period Buy Sel
May 2024 0 14242
Jun 2024 0 11160
Jul 2024 0 5500
Aug 2024 0 6250
Sep 2024 0 5000
Oct 2024 0 5000
Nov 2024 0 30000
Dec 2024 0 21083
Transaction Date Insider Security Shares Price per share Total value Source
Option
LIPPIS DANIEL J. officer: CVP, JAPAC
Common Stock 2,500 $45.28 $113,193
Sale
LIPPIS DANIEL J. officer: CVP, JAPAC
Common Stock 2,500 $74.08 $185,195
Option
LIPPIS DANIEL J. officer: CVP, JAPAC
Employee Stock Option (Right to Acquire) 2,500 $45.28 $113,193
Option
ULLEM SCOTT B. officer: CVP, Chi.. Employee Stock Option (Right to Acquire) 11,250 $45.28 $509,366
Option
ULLEM SCOTT B. officer: CVP, Chi.. Common Stock 11,250 $45.28 $509,366
Sale
ULLEM SCOTT B. officer: CVP, Chi.. Common Stock 11,250 $71.68 $806,411
Option
BOBO DONALD E JR officer: CVP,Stra.. Common Stock 5,000 $45.28 $226,385
Sale
BOBO DONALD E JR officer: CVP,Stra.. Common Stock 5,000 $71.75 $358,750
Option
BOBO DONALD E JR officer: CVP,Stra.. Employee Stock Option (Right to Acquire) 5,000 $45.28 $226,385
Sale
CHOPRA DAVEEN officer: CVP, TMTT
Common Stock 1,750 $73.27 $128,223
Patent
Grant
Filling date: 11 Feb 2020 Issue date: 20 Sep 2022
Grant
Filling date: 7 Feb 2020 Issue date: 20 Sep 2022
Grant
Filling date: 23 Dec 2019 Issue date: 20 Sep 2022
Grant
Filling date: 19 Jun 2020 Issue date: 13 Sep 2022
Application
Filling date: 27 May 2022 Issue date: 8 Sep 2022
Application
Filling date: 26 May 2022 Issue date: 8 Sep 2022
Application
Filling date: 25 May 2022 Issue date: 8 Sep 2022
Application
Filling date: 23 May 2022 Issue date: 8 Sep 2022
Application
Filling date: 23 May 2022 Issue date: 8 Sep 2022
Application
Filling date: 20 May 2022 Issue date: 8 Sep 2022
Friday, 20 December 2024
zacks.com
Friday, 13 December 2024
accesswire.com
accesswire.com
accesswire.com
globenewswire.com
zacks.com
accesswire.com
accesswire.com
accesswire.com
accesswire.com
accesswire.com
prnewswire.com
Thursday, 12 December 2024
accesswire.com
accesswire.com
globenewswire.com
accesswire.com
accesswire.com
businesswire.com
accesswire.com
prnewswire.com
accesswire.com
globenewswire.com
accesswire.com
accesswire.com
accesswire.com
accesswire.com
globenewswire.com
accesswire.com
accesswire.com
globenewswire.com
  • What's the price of Edwards Lifesciences stock today?

    One share of Edwards Lifesciences stock can currently be purchased for approximately $80.24.

  • When is Edwards Lifesciences's next earnings date?

    Unfortunately, Edwards Lifesciences's (EW) next earnings date is currently unknown.

  • Does Edwards Lifesciences pay dividends?

    No, Edwards Lifesciences does not pay dividends.

  • How much money does Edwards Lifesciences make?

    Edwards Lifesciences has a market capitalization of 43.35B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 11.56% to 6B US dollars.

  • What is Edwards Lifesciences's stock symbol?

    Edwards Lifesciences Corporation is traded on the NYSE under the ticker symbol "EW".

  • What is Edwards Lifesciences's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Edwards Lifesciences?

    Shares of Edwards Lifesciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Edwards Lifesciences's key executives?

    Edwards Lifesciences's management team includes the following people:

    • Mr. Michael A. Mussallem Chairman & Chief Executive Officer(age: 72, pay: $2,090,000)
    • Mr. Jean-Luc Lemercier Corporation Vice President of Europe, Middle East, Africa, Canada & Latin America(age: 68, pay: $1,130,000)
    • Mr. Scott B. Ullem Corporation Vice President & Chief Financial Officer(age: 58, pay: $1,060,000)
    • Mr. Larry L. Wood Corporation Vice President of Transcatheter Aortic Valve Replacement(age: 59, pay: $1,010,000)
    • Mr. Donald E. Bobo Jr. Corporation Vice President of Strategy & Corporation Devel.(age: 63, pay: $970,810)
  • How many employees does Edwards Lifesciences have?

    As Jul 2024, Edwards Lifesciences employs 19,800 workers.

  • When Edwards Lifesciences went public?

    Edwards Lifesciences Corporation is publicly traded company for more then 25 years since IPO on 27 Mar 2000.

  • What is Edwards Lifesciences's official website?

    The official website for Edwards Lifesciences is edwards.com.

  • Where are Edwards Lifesciences's headquarters?

    Edwards Lifesciences is headquartered at One Edwards Way, Irvine, CA.

  • How can i contact Edwards Lifesciences?

    Edwards Lifesciences's mailing address is One Edwards Way, Irvine, CA and company can be reached via phone at +94 92502500.

  • What is Edwards Lifesciences stock forecast & price target?

    Based on 11 Wall Street analysts` predicted price targets for Edwards Lifesciences in the last 12 months, the avarage price target is $74.15. The average price target represents a -7.58% change from the last price of $80.24.

Edwards Lifesciences company profile:

Edwards Lifesciences Corporation

edwards.com
Exchange:

NYSE

Full time employees:

19,800

Industry:

Medical - Devices

Sector:

Healthcare

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

One Edwards Way
Irvine, CA 92614

CIK: 0001099800
ISIN: US28176E1082
CUSIP: 28176E108